Myasthenia Gravis Clinical Trials Myasthenia Gravis RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis
Conditions:   Generalized Myasthenia Gravis;   Myasthenia Gravis Interventions:   Drug: ALXN2050;   Drug: Placebo Sponsor:   Alexion Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2022 Category: Research Source Type: clinical trials